+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Direct-to-Consumer Genetic Testing Market by Ancestry Testing, Health Risk Testing, Trait Testing, Nutritional And Fitness Testing, Pharmacogenomic Testing, Paternity Testing - Global Forecast 2025-2030- Product Image
Direct-to-Consumer Genetic Testing Market by Ancestry Testing, Health Risk Testing, Trait Testing, Nutritional And Fitness Testing, Pharmacogenomic Testing, Paternity Testing - Global Forecast 2025-2030- Product Image
Sale

Direct-to-Consumer Genetic Testing Market by Ancestry Testing, Health Risk Testing, Trait Testing, Nutritional And Fitness Testing, Pharmacogenomic Testing, Paternity Testing - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968843
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The direct-to-consumer genetic testing market is reshaping the landscape of personalized healthcare by empowering organizations and individuals to leverage advanced genomic insights for health management and innovation. Market participants face new dynamics as technology, regulation, and global adoption patterns redefine standards and growth strategies.

Market Snapshot: Direct-to-Consumer Genetic Testing

The direct-to-consumer genetic testing market grew from USD 2.36 billion in 2024 to USD 2.79 billion in 2025. It is projected to continue its rapid expansion at a CAGR of 17.26%, reaching USD 6.16 billion by 2030. This growth exemplifies the sector’s transition from niche services to a central component of data-driven healthcare experiences for both consumers and stakeholders.

Scope & Segmentation

  • Testing Categories: Ancestry, Health Risk, Trait, Nutritional and Fitness, Pharmacogenomic, Paternity.
  • Key Sub-segments: Autosomal, Mitochondrial, Y-Chromosome, Carrier Screening, Single Gene, Polygenic Risk, Cardiovascular, Oncology, Behavioral and Physical Traits, Wellness, Endurance Profiling, Muscle Performance, Nutrient Deficiencies, Cardiovascular Drugs, Oncology Drugs, Psychiatric Drugs (Antidepressants, Antipsychotics), Postnatal, Prenatal.
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific, including major countries such as the United States, Canada, Brazil, United Kingdom, Germany, China, India, and Australia.
  • Technologies & Methodologies: Next-generation sequencing, artificial intelligence, advanced bioinformatics, consent management systems, data encryption, cloud infrastructure, blockchain.
  • Key Industry Players: 23andMe, Ancestry.com, Color Health, EasyDNA, Gene by Gene, International Biosciences, Living DNA, MyHeritage, Nebula Genomics, Veritas Genetics.

Key Takeaways

  • Integration of digital health and telemedicine platforms enhances consumer engagement, enabling actionable personalized data without exclusive reliance on clinical channels.
  • Growth in service categories, from ancestry tracing to trait and pharmacogenomic testing, aligns provider strategies with evolving user preferences across global markets.
  • Demand for privacy and transparency is driving adoption of robust data security measures, including end-to-end encryption and transparent consent protocols.
  • Innovative partnerships between genetic testing firms and mobile health applications create integrated solutions supporting proactive health and fitness management.
  • Regulatory evolution, particularly in data governance and ethical testing standards, continues to influence market positioning and product differentiation.
  • Emergent market entrants are focusing on rapid at-home testing kits and remote consultation models, catering to a growing emphasis on privacy and convenience.

Tariff Impact on Direct-to-Consumer Genetic Testing

New tariffs initiated in 2025 for critical testing components have led to increased production costs, prompting suppliers to enhance local manufacturing and diversify sourcing. Leading organizations have adapted by exploring innovative pricing strategies and revising supply chains to sustain competitiveness while safeguarding margins. This shift has highlighted the necessity for flexibility, cost efficiency, and transparent supplier relationships to maintain market resilience.

Methodology & Data Sources

This report is based on a multi-stage methodology encompassing primary interviews with market players, healthcare providers, regulators, and consumer advocates. Additionally, structured surveys and secondary reviews of peer-reviewed publications, industry reports, regulatory filings, and statistical databases support a comprehensive, triangulated analysis. Subject matter expert review and cross-validation underpin data integrity at every stage.

Why This Report Matters

  • Supports senior decision-makers in benchmarking technology trends, compliance approaches, and regional adoption strategies for direct-to-consumer genetic testing.
  • Informs supply chain and partnership decisions with actionable insights on evolving tariffs and operational frameworks.
  • Provides clarity on market segmentation, enabling tailored portfolio development and targeted consumer engagement across diverse healthcare contexts.

Conclusion

As the direct-to-consumer genetic testing market advances, organizations that prioritize digital innovation, regulatory collaboration, and consumer-centric strategies are best positioned for sustained success. This report delivers a strategic roadmap to navigate emerging challenges and secure leadership within this high-growth sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of polygenic risk scores into consumer genetic testing services to enhance predictive accuracy
5.2. Shift toward privacy preserving data analysis methods in direct to consumer genetic testing platforms
5.3. Growth of targeted wellness recommendations driven by nutrigenomics and lifestyle genomics insights
5.4. Increasing partnerships between genetic testing companies and pharmaceutical firms for drug discovery pipelines
5.5. Expansion of ancestry tracing capabilities to include deep population genetics and haplogroup subclade analysis
5.6. Growing regulatory scrutiny and compliance requirements shaping direct to consumer genetic testing service offerings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Direct-to-Consumer Genetic Testing Market, by Ancestry Testing
8.1. Introduction
8.2. Autosomal
8.3. Mitochondrial
8.4. Y-Chromosome
9. Direct-to-Consumer Genetic Testing Market, by Health Risk Testing
9.1. Introduction
9.2. Monogenic Disease Risk
9.2.1. Carrier Screening
9.2.2. Single Gene Tests
9.3. Polygenic Disease Risk
9.3.1. Cardiovascular Risk
9.3.2. Oncology Risk
10. Direct-to-Consumer Genetic Testing Market, by Trait Testing
10.1. Introduction
10.2. Behavioral Traits
10.2.1. Sleep Patterns
10.2.2. Stress Response
10.3. Physical Traits
10.3.1. Eye Color
10.3.2. Hair Color
10.4. Wellness Traits
10.4.1. Caffeine Metabolism
10.4.2. Vitamin Absorption
11. Direct-to-Consumer Genetic Testing Market, by Nutritional And Fitness Testing
11.1. Introduction
11.2. Fitness Optimization
11.2.1. Endurance Profiling
11.2.2. Muscle Performance
11.3. Nutrient Deficiency
11.3.1. Mineral Deficiency
11.3.2. Vitamin D Deficiency
12. Direct-to-Consumer Genetic Testing Market, by Pharmacogenomic Testing
12.1. Introduction
12.2. Cardiovascular Drugs
12.3. Oncology Drugs
12.4. Psychiatric Drugs
12.4.1. Antidepressants
12.4.2. Antipsychotics
13. Direct-to-Consumer Genetic Testing Market, by Paternity Testing
13.1. Introduction
13.2. Postnatal
13.3. Prenatal
14. Americas Direct-to-Consumer Genetic Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Direct-to-Consumer Genetic Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Direct-to-Consumer Genetic Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. 23andMe Holding Co.
17.3.2. Ancestry.com LLC
17.3.3. Color Health, Inc.
17.3.4. EasyDNA Ltd.
17.3.5. Gene by Gene, Ltd.
17.3.6. International Biosciences Ltd.
17.3.7. Living DNA Ltd.
17.3.8. MyHeritage Ltd.
17.3.9. Nebula Genomics, Inc.
17.3.10. Veritas Genetics, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DIRECT-TO-CONSUMER GENETIC TESTING MARKET: RESEARCHAI
FIGURE 28. DIRECT-TO-CONSUMER GENETIC TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. DIRECT-TO-CONSUMER GENETIC TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. DIRECT-TO-CONSUMER GENETIC TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AUTOSOMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AUTOSOMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y-CHROMOSOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y-CHROMOSOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE GENE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE GENE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR RISK, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR RISK, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY RISK, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY RISK, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SLEEP PATTERNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SLEEP PATTERNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STRESS RESPONSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STRESS RESPONSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EYE COLOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EYE COLOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HAIR COLOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HAIR COLOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CAFFEINE METABOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CAFFEINE METABOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN ABSORPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN ABSORPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ENDURANCE PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ENDURANCE PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MUSCLE PERFORMANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MUSCLE PERFORMANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MINERAL DEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MINERAL DEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN D DEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN D DEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POSTNATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POSTNATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRENATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRENATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 159. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 160. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 161. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 162. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 163. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 164. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 165. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 166. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 167. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 168. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 169. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 170. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 171. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 172. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 173. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 174. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 175. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 176. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 177. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 180. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 181. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 182. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 183. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 184. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 185. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 186. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 189. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 190. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 191. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 192. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 193. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 194. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 195. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 196. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 197. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 204. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 205. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 208. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 209. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 210. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 211. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 214. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2024 (USD MILLION)
TABLE 282. EUROPE

Samples

Loading
LOADING...

Companies Mentioned

  • 23andMe Holding Co.
  • Ancestry.com LLC
  • Color Health, Inc.
  • EasyDNA Ltd.
  • Gene by Gene, Ltd.
  • International Biosciences Ltd.
  • Living DNA Ltd.
  • MyHeritage Ltd.
  • Nebula Genomics, Inc.
  • Veritas Genetics, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.16 Billion
Compound Annual Growth Rate17.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Consumer Genomics Market by Product Type (Consumables, Instruments, Services), Technology (Bioinformatics & Computational Tools, CRISPR Technology, DNA Sequencing), Test Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Consumer Genomics Market by Product Type (Consumables, Instruments, Services), Technology (Bioinformatics & Computational Tools, CRISPR Technology, DNA Sequencing), Test Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
DNA Test Kits Market by Test Type (Ancestry, Carrier Testing, Health Risk), Technology (Microarray, PCR, Sequencing), Product Type, End User - Global Forecast 2025-2030 - Product Image

DNA Test Kits Market by Test Type (Ancestry, Carrier Testing, Health Risk), Technology (Microarray, PCR, Sequencing), Product Type, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Direct-to-Consumer (DTC) Genetic Testing Market Report 2025 - Product Image

Direct-to-Consumer (DTC) Genetic Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Direct-to-Consumer Genetic Testing Market and Technologies - Product Image

Direct-to-Consumer Genetic Testing Market and Technologies

  • Report
  • 84 Pages
  • Global
From
Consumer Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Consumer Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From

About the Direct to Consumer Genetic Testing Market

Direct to Consumer Genetic Testing (DTCGT) is a type of genetic testing that allows individuals to access their genetic information without the need for a doctor or other healthcare provider. DTCGT companies provide genetic testing services directly to consumers, typically through a simple saliva sample. The results of the test can provide insight into an individual's ancestry, health risks, and other genetic traits. The DTCGT market has grown rapidly in recent years, driven by advances in genomics technology and the increasing availability of affordable testing services. Consumers are increasingly turning to DTCGT to gain access to their genetic information and to learn more about their health and ancestry. Some of the leading companies in the DTCGT market include 23andMe, AncestryDNA, Helix, and MyHeritage. These companies offer a range of services, from ancestry testing to health risk assessments. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.